Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details)

v3.22.1
STOCKHOLDERS' EQUITY (DEFICIT) (Details)
12 Months Ended
Dec. 10, 2021
USD ($)
$ / shares
shares
Oct. 28, 2021
USD ($)
$ / shares
shares
Sep. 02, 2021
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2020
$ / shares
Subsidiary, Sale of Stock [Line Items]          
Forward split ratio     4.555821    
Common stock, par value | $ / shares       $ 0.0001 $ 0.0001
Price per share | $ / shares       $ 4.00  
Proceeds from initial public offering       $ 25,378,663  
Net proceeds from offering   $ 24,547,086      
Repayment of debt   $ 783,257   3,000,000  
Repayment of convertible notes       783,257  
Warrants to purchase common shares | shares 225,000        
Warrants exercise price | $ / shares $ 4        
Proceeds from warrant exercises $ 900,000     $ 900,000  
Initial public offering          
Subsidiary, Sale of Stock [Line Items]          
Number of shares issued | shares   6,250,000      
Proceeds from initial public offering   $ 28,750,000      
Share Price | $ / shares   $ 4.00      
Over allotment          
Subsidiary, Sale of Stock [Line Items]          
Number of shares issued | shares   937,500